2019
DOI: 10.1590/0074-02760190079
|View full text |Cite
|
Sign up to set email alerts
|

Temporal evolution of antimicrobial resistance among Neisseria gonorrhoeae clinical isolates in the most populated South American Metropolitan Region

Abstract: A total of 124 Neisseria gonorrhoeae isolates recovered during a 12-year period (2003-2015) from outpatients assisted at Centro de Referência e Treinamento DST/AIDS-CRT of São Paulo city, Brazil, were analysed. The following resistance rates were observed: penicillin-59.6%, ciprofloxacin-15.3%, and azithromycin-6.7%. Although reduced susceptibility to these drugs was observed since 2003, no ceftriaxone-resistant isolates were detected. Ciprofloxacin- and azithromycin non-susceptible isol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…The studies provided data on AMR in the following countries: Argentina ( n = 10) 29 , 45 , 48 , 52–54 , 63 , 66 , 67 , 70 during 1993 and between 2000 and 2017; Brazil ( n = 9) 42 , 44 , 46 , 47 , 50 , 55 , 57 , 58 , 65 in 2003 to 2016; Colombia ( n = 2) 43 , 61 in 2009 to 2018; Peru ( n = 6) 56 , 59 , 60 , 62 , 68 , 69 in 2012 to 2017; Uruguay ( n = 1) 41 in 2010 and 2011; and Venezuela ( n = 1) 51 during 2008. There were also two studies reporting on AMR in various LAC countries from the WHO-GASP-LAC, one of which 49 reported resistance between 1990 and 2011 in 23 LAC countries, and the other reported data from 2010 and 2011 in seven LAC countries.…”
Section: Resultsmentioning
confidence: 99%
“…The studies provided data on AMR in the following countries: Argentina ( n = 10) 29 , 45 , 48 , 52–54 , 63 , 66 , 67 , 70 during 1993 and between 2000 and 2017; Brazil ( n = 9) 42 , 44 , 46 , 47 , 50 , 55 , 57 , 58 , 65 in 2003 to 2016; Colombia ( n = 2) 43 , 61 in 2009 to 2018; Peru ( n = 6) 56 , 59 , 60 , 62 , 68 , 69 in 2012 to 2017; Uruguay ( n = 1) 41 in 2010 and 2011; and Venezuela ( n = 1) 51 during 2008. There were also two studies reporting on AMR in various LAC countries from the WHO-GASP-LAC, one of which 49 reported resistance between 1990 and 2011 in 23 LAC countries, and the other reported data from 2010 and 2011 in seven LAC countries.…”
Section: Resultsmentioning
confidence: 99%
“…[8] Furthermore, Neisseria Gonorrhea is able to accumulate different mutations leading to the emergence of clinical isolates with clinically significant levels of resistance to currently or previously used antibiotics such as sulfadrugs, penicillins and tetracyclines which has led the WHO to consider adding N. Gonorrhea infections to the category of untreatable infections [9][10][11][12]. With the absence of effective vaccines, and the lack of prolonged immunity after infection due to multiple evading mechanisms, society relies on antibiotics to reduce the spread of the gonococcus in the community [6,13,14].…”
Section: Introductionmentioning
confidence: 99%